0af3d7d5ec37a2ff1b5593e7c0f4d985 301290.pdf e58887b88a3c755996b9f5079102ba33b27d1a32 301290.pdf ad64d68af8210012c77ae566aeeb713bf187d0e74550c4ddb67b429db9e25513 301290.pdf Title: Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial Subject: DOI: 10.1093/cid/ciad409; Clinical Infectious Diseases, 77, 11, 2023-07-19.; Abstract: Background: Molnupiravir is an orally administered antiviral authorized for COVID-19 treatment in adults at high risk of progression to severe disease. Here, we report secondary and post hoc analyses of participants’ self-reported symptoms in the MOVe-OUT trial, which evaluated molnupiravir initiated within 5 days of symptom onset in nonhospitalized, unvaccinated adults with mild-to-moderate, laboratory-confirmed COVID-19. Methods: Eligible participants completed a 15-item symptom diary daily from day 1 (randomization) through day 29, rating symptom severity as “none,” “mild,” “moderate,” or “severe”; loss of smell and loss of taste were rated as “yes” or “no.” Time to sustained symptom resolution/improvement was defined as the number of days from randomization to the first of 3 consecutive days of reduced severity, without subsequent relapse. Time to symptom progression was defined as the number Keywords: SARS-CoV-2; antiviral; β-D-N4-hydroxycytidine; clinical trial; public health Author: Yanfen Guan Creator: Servigistics Arbortext Advanced Print Publisher 11.1.4546/W-x64 Producer: PDFlib+PDI 9.0.7p3 (C++/Win64) CreationDate: Tue Nov 28 04:43:28 2023 CET ModDate: Tue Nov 28 11:09:00 2023 CET Custom Metadata: yes Metadata Stream: yes Tagged: yes UserProperties: no Suspects: no Form: none JavaScript: no Pages: 10 Encrypted: no Page size: 593.972 x 782.986 pts Page rot: 0 File size: 825838 bytes Optimized: yes PDF version: 1.6 name type encoding emb sub uni object ID ------------------------------------ ----------------- ---------------- --- --- --- --------- KLHIUE+TimesNewRomanPSMT CID TrueType Identity-H yes yes yes 704 0 SAUQKS+MinionPro-Regular Type 1C Custom yes yes yes 707 0 ZXHKMS+UniversLTStd-BoldCn Type 1C Custom yes yes yes 710 0 VCGSAM+UniversLTStd-LightCn Type 1C Custom yes yes yes 713 0 ZPEQUJ+MinionPro-BoldIt Type 1C Custom yes yes yes 716 0 XUZPUD+MinionPro-Bold Type 1C Custom yes yes yes 719 0 DVLOLX+UniversLTStd-LightCnObl Type 1C Custom yes yes yes 722 0 FIIVZA+UniversLTStd-Cn Type 1C Custom yes yes yes 725 0 JQHIBE+UniversLTStd-Black Type 1C Custom yes yes yes 87 0 SAFCJF+STIXGeneral-Regular Type 1C Custom yes yes yes 90 0 VIKKXI+MinionPro-It Type 1C Custom yes yes yes 104 0 RTAMBD+UniversLTStd-Light Type 1C Custom yes yes yes 102 0 UQFKLK+STIXGeneral-Bold Type 1C Custom yes yes yes 103 0 Jhove (Rel. 1.28.0, 2023-05-18) Date: 2024-10-01 02:43:34 CEST RepresentationInformation: 301290.pdf ReportingModule: PDF-hul, Rel. 1.12.4 (2023-03-16) LastModified: 2024-09-30 11:16:53 CEST Size: 825838 Format: PDF Version: 1.6 Status: Well-Formed, but not valid SignatureMatches: PDF-hul ErrorMessage: Invalid indirect destination - referenced object 'corciad409-FM1' cannot be found ID: PDF-HUL-149 ErrorMessage: edu.harvard.hul.ois.jhove.module.pdf.PdfInvalidException: Invalid indirect destination - referenced object 'corciad409-FM1' cannot be found ID: PDF-HUL-122 Offset: 815033 MIMEtype: application/pdf Profile: Linearized PDF, Tagged PDF PDFMetadata: Objects: 0 FreeObjects: 1 IncrementalUpdates: 0 DocumentCatalog: ViewerPreferences: HideToolbar: false HideMenubar: false HideWindowUI: false FitWindow: false CenterWindow: false DisplayDocTitle: true NonFullScreenPageMode: UseNone Direction: L2R ViewArea: CropBox ViewClip: CropBox PrintArea: CropBox PageClip: CropBox PageLayout: OneColumn PageMode: UseOutlines Language: en Outlines: Item: Title: Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial Destination: head1 Children: Item: Title: METHODS Destination: secciad409-s0 Children: Item: Title: Trial Design Destination: secciad409-s0.1 Item: Title: Outcomes Destination: secciad409-s0.2 Item: Title: Statistical Analysis Destination: secciad409-s0.3 Item: Title: RESULTS Destination: secciad409-s1 Item: Title: DISCUSSION Destination: secciad409-s2 Children: Item: Title: Conclusions Destination: secciad409-s2.1 Item: Title: Notes Destination: secciad409-s3 Item: Title: References Destination: reflist Filters: FilterPipeline: FlateDecode FilterPipeline: DCTDecode Images: Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 1333 ImageHeight: 682 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 1200 ImageHeight: 645 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 1050 ImageHeight: 728 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 933 ImageHeight: 1602 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 933 ImageHeight: 771 BitsPerSample: 8 BitsPerSampleUnit: integer Image: NisoImageMetadata: FormatName: image/jpg CompressionScheme: JPEG ImageWidth: 633 ImageHeight: 582 ColorSpace: RGB BitsPerSample: 8 BitsPerSampleUnit: integer Fonts: Type0: Font: BaseFont: KLHIUE+TimesNewRomanPSMT Encoding: Identity-H ToUnicode: true Type1: Font: BaseFont: DVLOLX+UniversLTStd-LightCnObl FontSubset: true FirstChar: 1 LastChar: 18 FontDescriptor: FontName: DVLOLX+UniversLTStd-LightCnObl Flags: Nonsymbolic, Italic FontBBox: -169, -271, 1065, 953 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: SAUQKS+MinionPro-Regular FontSubset: true FirstChar: 1 LastChar: 85 FontDescriptor: FontName: SAUQKS+MinionPro-Regular Flags: Nonsymbolic FontBBox: -290, -360, 1684, 989 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: FIIVZA+UniversLTStd-Cn FontSubset: true FirstChar: 1 LastChar: 10 FontDescriptor: FontName: FIIVZA+UniversLTStd-Cn Flags: Nonsymbolic FontBBox: -166, -250, 1000, 989 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: ZXHKMS+UniversLTStd-BoldCn FontSubset: true FirstChar: 1 LastChar: 68 FontDescriptor: FontName: ZXHKMS+UniversLTStd-BoldCn Flags: Nonsymbolic, ForceBold FontBBox: -83, -250, 1000, 969 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: RTAMBD+UniversLTStd-Light FontSubset: true FirstChar: 1 LastChar: 64 FontDescriptor: FontName: RTAMBD+UniversLTStd-Light Flags: Nonsymbolic FontBBox: -151, -250, 1000, 957 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: JQHIBE+UniversLTStd-Black FontSubset: true FirstChar: 1 LastChar: 21 FontDescriptor: FontName: JQHIBE+UniversLTStd-Black Flags: Nonsymbolic, ForceBold FontBBox: -153, -250, 992, 986 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: UQFKLK+STIXGeneral-Bold FontSubset: true FirstChar: 1 LastChar: 1 FontDescriptor: FontName: UQFKLK+STIXGeneral-Bold Flags: Nonsymbolic, ForceBold FontBBox: -1030, -455, 2000, 1055 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: VIKKXI+MinionPro-It FontSubset: true FirstChar: 1 LastChar: 2 FontDescriptor: FontName: VIKKXI+MinionPro-It Flags: Nonsymbolic, Italic FontBBox: -201, -360, 1684, 1002 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: VCGSAM+UniversLTStd-LightCn FontSubset: true FirstChar: 1 LastChar: 81 FontDescriptor: FontName: VCGSAM+UniversLTStd-LightCn Flags: Nonsymbolic FontBBox: -163, -250, 1000, 953 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: SAFCJF+STIXGeneral-Regular FontSubset: true FirstChar: 1 LastChar: 5 FontDescriptor: FontName: SAFCJF+STIXGeneral-Regular Flags: Nonsymbolic FontBBox: -995, -455, 2000, 1055 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: ZPEQUJ+MinionPro-BoldIt FontSubset: true FirstChar: 1 LastChar: 31 FontDescriptor: FontName: ZPEQUJ+MinionPro-BoldIt Flags: Nonsymbolic, Italic, ForceBold FontBBox: -230, -360, 1684, 1032 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true Font: BaseFont: XUZPUD+MinionPro-Bold FontSubset: true FirstChar: 1 LastChar: 32 FontDescriptor: FontName: XUZPUD+MinionPro-Bold Flags: Nonsymbolic, ForceBold FontBBox: -318, -360, 1684, 1024 FontFile3: true EncodingDictionary: BaseEncoding: WinAnsiEncoding Differences: true ToUnicode: true CIDFontType2: Font: BaseFont: KLHIUE+TimesNewRomanPSMT CIDSystemInfo: Registry: Adobe Registry: Identity Supplement: 0 FontDescriptor: FontName: KLHIUE+TimesNewRomanPSMT Flags: Nonsymbolic FontBBox: -568, -307, 2046, 1040 FontFile2: true XMP: uuid:0a022420-2541-46d5-a32e-e47990925d98 uuid:069BD529-2AF4-EF3D-E88F-B8B8416076DA True SARS-CoV-2; antiviral; β-D-N4-hydroxycytidine; clinical trial; public health PDFlib+PDI 9.0.7p3 (C++/Win64) application/pdf 10.1093/cid/ciad409 en Oxford University Press Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial Yanfen Guan Amy Puenpatom Matthew G. Johnson Ying Zhang Yujie Zhao Joseph Surber Aaron Weinberg Carlos Brotons Roman Kozlov Rudy Lopez Kathleen Coetzee Joel Santiaguel Jiejun Du Angela Williams-Diaz Michelle Brown Amanda Paschke Carisa De Anda Josephine M. Norquist DOI: 10.1093/cid/ciad409; Clinical Infectious Diseases, 77, 11, 2023-07-19.; Abstract: Background: Molnupiravir is an orally administered antiviral authorized for COVID-19 treatment in adults at high risk of progression to severe disease. Here, we report secondary and post hoc analyses of participants’ self-reported symptoms in the MOVe-OUT trial, which evaluated molnupiravir initiated within 5 days of symptom onset in nonhospitalized, unvaccinated adults with mild-to-moderate, laboratory-confirmed COVID-19. Methods: Eligible participants completed a 15-item symptom diary daily from day 1 (randomization) through day 29, rating symptom severity as “none,” “mild,” “moderate,” or “severe”; loss of smell and loss of taste were rated as “yes” or “no.” Time to sustained symptom resolution/improvement was defined as the number of days from randomization to the first of 3 consecutive days of reduced severity, without subsequent relapse. Time to symptom progression was defined as the number © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. SARS-CoV-2 antiviral β-D-N4-hydroxycytidine clinical trial public health Journal Clinical Infectious Diseases © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 1058-4838 1537-6591 77 11 1521 1530 10.1093/cid/ciad409 https://doi.org/10.1093/cid/ciad409 2023-11-28T09:13:28+05:30 2023-11-28T15:39+05:30 Servigistics Arbortext Advanced Print Publisher 11.1.4546/W-x64 2023-11-28T15:39+05:30 PStill version 1.84.42 1 PDF/UA Universal Accessibility Schema http://www.aiim.org/pdfua/ns/id/ pdfuaid part Integer internal Indicates, which part of ISO 14289 standard is followed Pages: Page: Sequence: 1 Annotations: Annotation: Subtype: Link Rect: 92, 618, 95, 626 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 152, 618, 154, 626 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 226, 618, 229, 626 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 270, 618, 273, 626 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 312, 618, 314, 626 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 366, 618, 369, 626 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 427, 618, 429, 626 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 482, 618, 484, 626 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 534, 618, 537, 626 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 87, 608, 90, 616 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 151, 608, 153, 616 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 209, 608, 212, 616 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 247, 608, 250, 616 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 251, 608, 254, 616 Flags: Print Destination: null Annotation: Subtype: Link Rect: 330, 608, 332, 616 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 390, 608, 392, 616 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 453, 608, 456, 616 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 511, 608, 514, 616 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 137, 598, 140, 606 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 422, 202, 427, 211 Flags: Print Destination: 29 Annotation: Subtype: Link Rect: 431, 202, 436, 211 Flags: Print Destination: 29 Annotation: Subtype: Link Rect: 371, 124, 375, 133 Flags: Print Destination: 29 Annotation: Subtype: Link Rect: 50, 154, 116, 161 Flags: Print Annotation: Subtype: Link Rect: 152, 107, 284, 114 Flags: Print Annotation: Subtype: Link Rect: 48, 71, 139, 78 Flags: Print Page: Sequence: 2 Annotations: Annotation: Subtype: Link Rect: 74, 721, 79, 730 Flags: Print Destination: 29 Annotation: Subtype: Link Rect: 70, 669, 75, 678 Flags: Print Destination: 29 Annotation: Subtype: Link Rect: 80, 669, 89, 678 Flags: Print Destination: 29 Annotation: Subtype: Link Rect: 224, 604, 229, 613 Flags: Print Destination: 29 Annotation: Subtype: Link Rect: 234, 604, 243, 613 Flags: Print Destination: 29 Annotation: Subtype: Link Rect: 52, 552, 61, 561 Flags: Print Destination: 29 Annotation: Subtype: Link Rect: 52, 487, 61, 496 Flags: Print Destination: 29 Annotation: Subtype: Link Rect: 66, 487, 75, 496 Flags: Print Destination: 33 Annotation: Subtype: Link Rect: 239, 435, 248, 444 Flags: Print Destination: 33 Annotation: Subtype: Link Rect: 173, 175, 178, 184 Flags: Print Destination: 29 Annotation: Subtype: Link Rect: 184, 175, 193, 184 Flags: Print Destination: 33 Annotation: Subtype: Link Rect: 503, 435, 512, 444 Flags: Print Destination: 33 Annotation: Subtype: Link Rect: 309, 356, 318, 366 Flags: Print Destination: 33 Page: Sequence: 3 Annotations: Annotation: Subtype: Link Rect: 249, 162, 258, 171 Flags: Print Destination: 33 Annotation: Subtype: Link Rect: 512, 240, 539, 249 Flags: Print Destination: 7 Annotation: Subtype: Link Rect: 482, 201, 510, 210 Flags: Print Destination: 7 Annotation: Subtype: Link Rect: 333, 136, 364, 145 Flags: Print Destination: 12 Page: Sequence: 4 Annotations: Annotation: Subtype: Link Rect: 52, 149, 81, 158 Flags: Print Destination: 12 Annotation: Subtype: Link Rect: 202, 110, 234, 119 Flags: Print Destination: 16 Annotation: Subtype: Link Rect: 234, 71, 271, 80 Flags: Print Destination: 16 Annotation: Subtype: Link Rect: 413, 366, 450, 376 Flags: Print Destination: 16 Annotation: Subtype: Link Rect: 426, 288, 457, 298 Flags: Print Destination: 21 Annotation: Subtype: Link Rect: 422, 223, 452, 233 Flags: Print Destination: 25 Annotation: Subtype: Link Rect: 309, 145, 339, 155 Flags: Print Destination: 29 Page: Sequence: 5 Annotations: Annotation: Subtype: Link Rect: 240, 71, 249, 80 Flags: Print Destination: 33 Annotation: Subtype: Link Rect: 516, 214, 525, 223 Flags: Print Destination: 33 Annotation: Subtype: Link Rect: 333, 84, 342, 93 Flags: Print Destination: 33 Page: Sequence: 6 Page: Sequence: 7 Page: Sequence: 8 Annotations: Annotation: Subtype: Link Rect: 165, 240, 174, 249 Flags: Print Destination: 33 Annotation: Subtype: Link Rect: 179, 240, 188, 249 Flags: Print Destination: 33 Annotation: Subtype: Link Rect: 223, 162, 233, 171 Flags: Print Destination: 33 Annotation: Subtype: Link Rect: 237, 162, 247, 171 Flags: Print Destination: 33 Annotation: Subtype: Link Rect: 52, 71, 61, 80 Flags: Print Destination: 33 Page: Sequence: 9 Annotations: Annotation: Subtype: Link Rect: 306, 455, 471, 463 Flags: Print Annotation: Subtype: Link Rect: 360, 435, 436, 443 Flags: Print Annotation: Subtype: Link Rect: 306, 359, 312, 366 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 306, 332, 312, 339 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 306, 314, 312, 321 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 306, 287, 312, 294 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 306, 269, 312, 276 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 306, 242, 312, 249 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 306, 224, 312, 231 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 306, 197, 312, 204 Flags: Print Destination: 645 Annotation: Subtype: Link Rect: 306, 170, 312, 177 Flags: Print Destination: 1 Annotation: Subtype: Link Rect: 306, 143, 312, 150 Flags: Print Destination: 1 Annotation: Subtype: Link Rect: 306, 125, 312, 132 Flags: Print Destination: 1 Annotation: Subtype: Link Rect: 306, 98, 312, 105 Flags: Print Destination: 1 Page: Sequence: 10 Annotations: Annotation: Subtype: Link Rect: 48, 736, 55, 743 Flags: Print Destination: 1 Annotation: Subtype: Link Rect: 48, 708, 55, 715 Flags: Print Destination: 1 Annotation: Subtype: Link Rect: 48, 650, 55, 657 Flags: Print Destination: 1 Annotation: Subtype: Link Rect: 48, 622, 55, 629 Flags: Print Destination: 1 Annotation: Subtype: Link Rect: 108, 612, 288, 619 Flags: Print Annotation: Subtype: Link Rect: 60, 603, 104, 610 Flags: Print Annotation: Subtype: Link Rect: 48, 594, 55, 601 Flags: Print Destination: 4 Annotation: Subtype: Link Rect: 306, 736, 312, 743 Flags: Print Destination: 12 Annotation: Subtype: Link Rect: 306, 700, 312, 707 Flags: Print Destination: 25 Annotation: Subtype: Link Rect: 306, 673, 312, 680 Flags: Print Destination: 25 Annotation: Subtype: Link Rect: 306, 655, 312, 662 Flags: Print Destination: 25 Annotation: Subtype: Link Rect: 306, 610, 312, 617 Flags: Print Destination: 25 Annotation: Subtype: Link Rect: 306, 583, 312, 590 Flags: Print Destination: 25 Checksum: 9a721b72 Type: CRC32 Checksum: 0af3d7d5ec37a2ff1b5593e7c0f4d985 Type: MD5 Checksum: e58887b88a3c755996b9f5079102ba33b27d1a32 Type: SHA-1 Checksum: ad64d68af8210012c77ae566aeeb713bf187d0e74550c4ddb67b429db9e25513 Type: SHA-256